Literature DB >> 24436428

Exosomes: nanoparticles involved in cardioprotection?

Derek M Yellon1, Sean M Davidson.   

Abstract

Exosomes are nanosized lipid vesicles released from cells. They are capable of transferring proteins, mRNA, and miRNA between cells and, therefore, represent a potential means of intercellular communication. Exosomes can be proangiogenic and may have cardioprotective properties. In contrast, their larger cousins, microvesicles, seem to have generally detrimental effects that are prothrombotic and proinflammatory. Exosomes are released from multivesicular bodies via an exocytic pathway and have the potential for cell-specific targeting. This normal process is hijacked during various pathological conditions, such as cancer, viral infection, and amyloidopathies. We assess the evidence for a role of exosomes and microvesicles in normal cardiovascular physiology, as well as during cardiovascular disease. In addition to offering a potential source of cardiovascular biomarkers, exosomes may offer a nonimmunogenic means of manipulating the heart.

Entities:  

Keywords:  cardiovascular diseases; exosomes; heart

Mesh:

Year:  2014        PMID: 24436428     DOI: 10.1161/CIRCRESAHA.113.300636

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  72 in total

1.  Comparison of Non-Coding RNAs in Exosomes and Functional Efficacy of Human Embryonic Stem Cell- versus Induced Pluripotent Stem Cell-Derived Cardiomyocytes.

Authors:  Won Hee Lee; Wen-Yi Chen; Ning-Yi Shao; Dan Xiao; Xulei Qin; Natalie Baker; Hye Ryeong Bae; Tzu-Tang Wei; Yongjun Wang; Praveen Shukla; Haodi Wu; Kazuki Kodo; Sang-Ging Ong; Joseph C Wu
Journal:  Stem Cells       Date:  2017-07-31       Impact factor: 6.277

Review 2.  Exosomes Generated From iPSC-Derivatives: New Direction for Stem Cell Therapy in Human Heart Diseases.

Authors:  Ji-Hye Jung; Xuebin Fu; Phillip C Yang
Journal:  Circ Res       Date:  2017-01-20       Impact factor: 17.367

Review 3.  Cardioprotection by remote ischemic conditioning and its signal transduction.

Authors:  Petra Kleinbongard; Andreas Skyschally; Gerd Heusch
Journal:  Pflugers Arch       Date:  2016-12-07       Impact factor: 3.657

4.  Circulating Exosomes Induced by Cardiac Pressure Overload Contain Functional Angiotensin II Type 1 Receptors.

Authors:  Gianluigi Pironti; Ryan T Strachan; Dennis Abraham; Samuel Mon-Wei Yu; Minyong Chen; Wei Chen; Kenji Hanada; Lan Mao; Lewis J Watson; Howard A Rockman
Journal:  Circulation       Date:  2015-05-20       Impact factor: 29.690

5.  Myocardial reparative functions of exosomes from mesenchymal stem cells are enhanced by hypoxia treatment of the cells via transferring microRNA-210 in an nSMase2-dependent way.

Authors:  Jinyun Zhu; Kai Lu; Ning Zhang; Yun Zhao; Qunchao Ma; Jian Shen; Yinuo Lin; Pingping Xiang; Yaoliang Tang; Xinyang Hu; Jinghai Chen; Wei Zhu; Keith A Webster; Jian'an Wang; Hong Yu
Journal:  Artif Cells Nanomed Biotechnol       Date:  2017-11-16       Impact factor: 5.678

6.  Exosomes in disease and regeneration: biological functions, diagnostics, and beneficial effects.

Authors:  Yun Lin; Johnathon D Anderson; Lily M A Rahnama; Shenwen V Gu; Anne A Knowlton
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-09-28       Impact factor: 4.733

Review 7.  Generation of cardiac progenitor cells through epicardial to mesenchymal transition.

Authors:  Antonia Germani; Eleonora Foglio; Maurizio C Capogrossi; Matteo Antonio Russo; Federica Limana
Journal:  J Mol Med (Berl)       Date:  2015-05-07       Impact factor: 4.599

Review 8.  Remote ischemic conditioning.

Authors:  Gerd Heusch; Hans Erik Bøtker; Karin Przyklenk; Andrew Redington; Derek Yellon
Journal:  J Am Coll Cardiol       Date:  2015-01-20       Impact factor: 24.094

9.  Macrophage-Derived mir-155-Containing Exosomes Suppress Fibroblast Proliferation and Promote Fibroblast Inflammation during Cardiac Injury.

Authors:  Chunxiao Wang; Congcong Zhang; Luxin Liu; Xi A; Boya Chen; Yulin Li; Jie Du
Journal:  Mol Ther       Date:  2017-01-04       Impact factor: 11.454

10.  microRNA-144: the 'what' and 'how' of remote ischemic conditioning?

Authors:  Karin Przyklenk
Journal:  Basic Res Cardiol       Date:  2014-07-31       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.